# A Multifaceted Intervention to Improve Bleeding Management Among Patients Using Oral Anticoagulants (IMPACT-BLEEDING)

> **NCT06575517** · — · WITHDRAWN · sponsor: **AstraZeneca**

## Conditions studied

- Bleeding

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06575517
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-01-13
- **Primary completion:** 2025-01-13
- **Final completion:** 2025-01-13
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was withdrawn due to a realignment of strategic priorities.
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06575517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06575517, "A Multifaceted Intervention to Improve Bleeding Management Among Patients Using Oral Anticoagulants (IMPACT-BLEEDING)". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06575517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*